Purpose of Review COVID-19 is highly contagious; since it was first identified, the virus has
rapidly spread to more than 100 countries and was declared a pandemic on March 11 …

Limited information is available on the impact of the COVID‐19 pandemic on the
management of chronic myeloid leukaemia (CML). The Campus CML network collected …

We do not know the precise figure for solid organ tumors diagnosed each year in Spain and
it is therefore difficult to calculate whether there has been a decrease in cancer diagnoses …

To explore the prevalence and severity of COVID-19 and the mental health during the
Omicron pandemic in patients with chronic myeloid leukemia (CML), a cross-sectional …

Since the beginning of the COVID-19 pandemic, there has been an overall improvement in
patient mortality. However, haematological malignancy patients continue to experience …

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral
agent responsible for the coronavirus disease of 2019. The disease is primarily a respiratory …

Materials and methods Retrospective data from the records of the National Center for
Cancer Care and Research from December 20, 2021, to January 30, 2022. Participants …

2. METHODS Our retrospective study from 30 December 2020 through 29 March 2021
included unselected consecutive hematological patients diagnosed with COVID‐19 …

(1) Background: Chronic myeloid leukemia (CML) is a blood dyscrasia that accounts for
about 20% of all leukemia cases. Tyrosine kinase inhibitors (TKIs) are used as first line …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel b coronavirus, has
led to very significant global healthcare challenges. Development of cellular immunity …